The Role of Obesity, Body Composition, and Nutrition in COVID-19 Pandemia: A Narrative Review

被引:10
|
作者
Rossi, Andrea P. [1 ]
Muollo, Valentina [2 ]
Dalla Valle, Zeno [3 ]
Urbani, Silvia [3 ]
Pellegrini, Massimo [4 ]
El Ghoch, Marwan [4 ,5 ]
Mazzali, Gloria [3 ]
机构
[1] Osped Ca Foncello, Div Geriatr, Dept Med, I-31100 Treviso, Italy
[2] Univ Verona, Dept Med, I-37126 Verona, Italy
[3] Univ Verona, Dept Med, Geriatr Div, I-37126 Verona, Italy
[4] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, I-41121 Modena, Italy
[5] Beirut Arab Univ, Fac Hlth Sci, Dept Nutr & Dietet, POB 11-5020, Beirut, Lebanon
关键词
SARS-CoV-2; COVID-19; obesity; body mass index; intensive care units; EPICARDIAL ADIPOSE-TISSUE; MUSCLE STRENGTH; OUTCOMES; FAT; INFLAMMATION; ASSOCIATION; DYSFUNCTION; THROMBOSIS; INFECTION; PROTEIN;
D O I
10.3390/nu14173493
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The coronavirus disease 2019 (COVID-19) pandemic has spread worldwide, infecting nearly 500 million people, with more than 6 million deaths recorded globally. Obesity leads people to be more vulnerable, developing worse outcomes that can require hospitalization in intensive care units (ICU). This review focused on the available findings that investigated the link between COVID-19, body composition, and nutritional status. Most studies showed that not only body fat quantity but also its distribution seems to play a crucial role in COVID-19 severity. Compared to the body mass index (BMI), visceral adipose tissue and intrathoracic fat are better predictors of COVID-19 severity and indicate the need for hospitalization in ICU and invasive mechanical ventilation. High volumes of epicardial adipose tissue and its thickness can cause an infection located in the myocardial tissue, thereby enhancing severe COVID-related myocardial damage with impairments in coronary flow reserve and thromboembolism. Other important components such as sarcopenia and intermuscular fat augment the vulnerability in contracting COVID-19 and increase mortality, inflammation, and muscle damage. Malnutrition is prevalent in this population, but a lack of knowledge remains regarding the beneficial effects aimed at optimizing nutritional status to limit catabolism and preserve muscle mass. Finally, with the increase in patients recovering from COVID-19, evaluation and treatment in those with Long COVID syndrome may become highly relevant.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Nutrition in the Actual COVID-19 Pandemic. A Narrative Review
    Clemente-Suarez, Vicente Javier
    Ramos-Campo, Domingo Jesus
    Mielgo-Ayuso, Juan
    Dalamitros, Athanasios A.
    Nikolaidis, Pantelis A.
    Hormeno-Holgado, Alberto
    Tornero-Aguilera, Jose Francisco
    NUTRIENTS, 2021, 13 (06)
  • [22] COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury
    Lasbleiz, Adele
    Gaborit, Benedicte
    Soghomonian, Astrid
    Bartoli, Axel
    Ancel, Patricia
    Jacquier, Alexis
    Dutour, Anne
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [23] Obesity augments the disease burden in COVID-19: Updated data from an umbrella review
    Kristensen, Nickolai M.
    Gribsholt, Sigrid B.
    Andersen, Anton L.
    Richelsen, Bjorn
    Bruun, Jens M.
    CLINICAL OBESITY, 2022, 12 (03)
  • [24] Coronavirus disease 2019 (COVID-19) pathogenesis: a concise narrative review
    Elhamzaoui, Hamza
    Rebahi, Houssam
    Hachimi, Abdelhamid
    PAN AFRICAN MEDICAL JOURNAL, 2021, 39
  • [25] Obesity pandemic during COVID-19 outbreak: Narrative review and future considerations
    Cava, Edda
    Neri, Barbara
    Carbonelli, Maria Grazia
    Riso, Sergio
    Carbone, Salvatore
    CLINICAL NUTRITION, 2021, 40 (04) : 1637 - 1643
  • [26] COVID-19 in Children: A Narrative Review
    Ha, Jennifer F.
    CURRENT PEDIATRIC REVIEWS, 2021, 17 (03) : 212 - 219
  • [27] Ibuprofen, other NSAIDs and COVID-19: a narrative review
    Laughey, William
    Lodhi, Imran
    Pennick, Graham
    Smart, Lucinda
    Sanni, Olutoba
    Sandhu, Suneet
    Charlesworth, Bruce
    INFLAMMOPHARMACOLOGY, 2023, 31 (05) : 2147 - 2159
  • [28] COVID-19 and corticosteroids: a narrative review
    Batiha, Gaber El-Saber
    Al-Gareeb, Ali, I
    Saad, Hebatallah M.
    Al-kuraishy, Hayder M.
    INFLAMMOPHARMACOLOGY, 2022, 30 (04) : 1189 - 1205
  • [29] Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review
    Vilaplana-Carnerero, Carles
    Giner-Soriano, Maria
    Dominguez, Angela
    Morros, Rosa
    Pericas, Carles
    alamo-Junquera, Dolores
    Toledo, Diana
    Gallego, Carmen
    Redondo, Ana
    Grau, Maria
    BIOMEDICINES, 2023, 11 (04)
  • [30] COVID-19 and Chronic Kidney Disease: A Narrative Review
    Martins, Marilia Paiva
    de Oliveira, Rodrigo Bueno
    COVID, 2023, 3 (08): : 1092 - 1105